Powder: -20°C for 3 years | In solvent: -80°C for 1 year
1. Atractylenolide-I has an anti-inflammatory effect by inhibiting TNF-α and IL-6 production; ameliorates sepsis syndrome, liver and kidney functions by reduction of pro-inflammatory cytokines and LPS. 2. Atractylenolide-I significantly sensitizes the response of MyD88(+) EOC cells to paclitaxel by blocking MD-2-mediated TLR4/MyD88 signaling.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 36.00 | |
5 mg | In stock | $ 79.00 | |
10 mg | In stock | $ 133.00 | |
25 mg | In stock | $ 253.00 | |
50 mg | In stock | $ 446.00 | |
100 mg | In stock | $ 623.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 96.00 |
Description | 1. Atractylenolide-I has an anti-inflammatory effect by inhibiting TNF-α and IL-6 production; ameliorates sepsis syndrome, liver and kidney functions by reduction of pro-inflammatory cytokines and LPS. 2. Atractylenolide-I significantly sensitizes the response of MyD88(+) EOC cells to paclitaxel by blocking MD-2-mediated TLR4/MyD88 signaling. |
Source |
Molecular Weight | 230.3 |
Formula | C15H18O2 |
CAS No. | 73069-13-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (238.81 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Atractylenolide I 73069-13-3 Angiogenesis Apoptosis Chromatin/Epigenetic Immunology/Inflammation JAK/STAT signaling Stem Cells TNF IL Receptor JAK TLR STAT Janus kinase Inhibitor Toll-like Receptor (TLR) inhibit inhibitor